This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked MYH8 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MYH8 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~222.8 kDa | |
| Gel | 4–12% gradient (standard starting point) | |
| Positive control | Skeletal muscle (IHC candidate; verify WB) +1 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Methylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A08502 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HeLa cell lysate (catalog A08502) |
| Gel % | 4–12% gradient (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A08502 · (A) 0.5 and (B) 1 μg/ml (catalog A08502) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
MYH8 has a predicted heavy-chain mass of 222.8 kDa; its listed modifications and myosin assembly could affect appearance, but altered migration is not demonstrated.
| Band near 222.8 kDa | consistent with the predicted MYH8 heavy chain; confirm identity with controls |
| Higher molecular mass band | may reflect incomplete dissociation of the myosin complex |
| Nearby doublet | different phosphorylation states are possible, but distinct migration is unproven |
| Faint or absent band in cell lysate | MYH8 is a myofibrillar muscle protein and may be scarce in the sampled cells |
| Predicted MYH8 heavy-chain mass | places the unmodified sequence near 222.8 kDa |
| Phosphothreonine at residues 66 and 71 | may affect mobility, but no visible shift is established |
| Phosphotyrosine at residue 389 | may affect mobility, but no visible shift is established |
| Trimethyllysine at residue 132 | adds a small modification; no visible shift is established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | MYH8 is localized to muscle myofibrils and may be scarce in the sample | check a skeletal-muscle positive control and retain myofibrillar material during extraction |
| Band higher than expected | the myosin complex may be incompletely dissociated | check denaturation and compare with a well-denatured control |
| Band lower than expected | band identity or protein integrity is uncertain | compare with a positive control and verify specificity with an independent MYH8 antibody |
| Multiple bands | modification states are possible, but distinct MYH8 bands are unproven | compare with a positive control and verify each band with an independent antibody |
| Weak or no signal | the sample may contain little myofibrillar MYH8 | check a skeletal-muscle positive control and confirm protein recovery |
| Fragments below expected size | MYH8 may have degraded during sample preparation | prepare fresh samples with protease inhibitors and compare with a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Skeletal muscle | myocytes | High | Protein (IHC) | HPA → |
| Testis | Leydig cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for MYH8, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
the supplier A08502 is an anti-MYH8 antibody listed as reactive with human, mouse, and rat. Its Western blot image shows HeLa cell lysate tested at 0.5 and 1 μg/ml. The supplied evidence does not show Western blot results in mouse or rat samples.
Which to pick: A08502 is the only listed MYH8 antibody and has a Western blot image using HeLa cell lysate. For mouse or rat samples, the catalog lists reactivity, but no Western blot example is supplied.